BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 176 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2020. The put-call ratio across all filers is 0.12 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $9,165,000 | +30.0% | 168,343 | -0.4% | 1.02% | +16.6% |
| Q3 2019 | $7,052,000 | +1.4% | 169,042 | +6.5% | 0.88% | +2.6% |
| Q2 2019 | $6,952,000 | -15.1% | 158,752 | -0.2% | 0.86% | -21.0% |
| Q1 2019 | $8,186,000 | +36.7% | 159,052 | -1.8% | 1.08% | +15.2% |
| Q4 2018 | $5,988,000 | -5.5% | 161,932 | -4.1% | 0.94% | +16.7% |
| Q3 2018 | $6,339,000 | +12.5% | 168,820 | +18.4% | 0.81% | +4.1% |
| Q2 2018 | $5,636,000 | +61.0% | 142,620 | +5.0% | 0.77% | +47.1% |
| Q1 2018 | $3,500,000 | – | 135,880 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 450,422 | $6,251,857 | 14.11% |
| Liontrust Investment Partners LLP | 134,659 | $7,478,961 | 0.13% |
| Birchview Capital, LP | 7,365 | $102 | 0.07% |
| FNY Investment Advisers, LLC | 250 | $3 | 0.00% |
| FNY Investment Advisers, LLC | 18 | $0 | 0.00% |
| FNY Investment Advisers, LLC | 56 | $0 | 0.00% |
| McElhenny Sheffield Capital Management, LLC | 31 | $430 | 0.00% |
| Blue Trust, Inc. | 65 | $10 | 0.00% |
| IFP Advisors, Inc | 1 | $1 | 0.00% |